Eugenio Fava is an enthusiastic scientist with experience in neuroscience and drug discovery. Eugenio is leading the Core Research Facilities & Services at DZNE (Deutsches Zentrum für Neurodegenerative Erkrankungen - German Center for Neurodegenerative Diseases) where he established a set of innovative platforms with the focus to transfer bench scale research to an industrial standard for preclinical drug discovery. Eugenio aims to develop and use innovative technologies on both technology and cell-based assays to achieve the delivery of therapeutical intervention in CNS diseases. Eugenio has a strong interest in the integration of high content data with computational and research technologies to develop new methods for the application in cell biology and in early drug discovery.